20Indexed trials
mesh condition
Cerebral Hemorrhage
Intelligence
Cerebral Hemorrhage intelligence: 20 indexed trials, 7 recruiting studies, 19 sponsors across 20 countries.
7Recruiting
19Sponsors
20Countries
Leading sponsors
Massachusetts General Hospital22 recruiting
Bispebjerg Hospital10 recruiting
Li Hai10 recruiting
MD Stem Cells11 recruiting
Mansoura University Hospital10 recruiting
Melbourne Health11 recruiting
National Taiwan University Hospital10 recruiting
OSF Healthcare System10 recruiting
Penumbra Inc.10 recruiting
Region Skane11 recruiting
Rong Hu, MD10 recruiting
Tang Zhouping11 recruiting
Geographic activity
United States7trials
China4trials
Australia2trials
Canada2trials
Germany2trials
Taiwan2trials
United Arab Emirates1trials
Hong Kong1trials
Iceland1trials
Italy1trials
Japan1trials
Malaysia1trials
Leading interventions
Artemis Neuro Evacuation Device1trials
Auricular Press-Needle Therapy1trials
Best medical treatment (BMT)1trials
Cattle Encephalon Glycoside and Ignotin1trials
Conventional Neurosurgical and Supportive Care1trials
Device: Phase II MTD in Phase I1trials
Device: Phase II lower than the MTD in Phase I1trials
Device: Phase Ⅰ Dose Level 11trials
Device: Phase Ⅰ Dose Level 21trials
Device: Phase Ⅰ Dose Level 31trials
Do-not-resuscitate (DNR) or withdrawal of care1trials
1. amyloid PET；2. T807 PET1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.